Boston Scientific (NYSE:BSX) said yesterday it inked a sales and marketing deal with cardio-focused remote patient care company Preventice Solutions. The new deal will position medical device giant Boston Scientific as Preventice’s exclusive sales and marketing representative for its cardiology-related diagnostic and monitoring offerings, the companies said. “This agreement marks an important strategic milestone for Preventice Solutions. […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Sorin claims its new CRT-P is the world’s smallest
Sorin Group (BIT:SRN) said today it launched its Reply CRT-P cardiac resynchronization therapy pacemaker, claiming it to be the world’s smallest of its kind. The Reply CRT-P is 11.3 cc in volume, 3.7 cc smaller than Boston Scientific‘s (NYSE:BSX) Intua and 0.2 cc smaller than St. Jude Medical‘s (NYSE:STJ) Anthem CRT-P, according to their respective sites. The […]
Sorin’s Q2 earnings plunge on Cyberonics merger costs
Sorin Group (BIT:SRN) said yesterday that its 2nd-quarter profits plunged nearly 80% , largely due to costs from its pending, $2.7 billion merger with Cyberonics (NSDQ:CYBX). Milan-based Sorin said profits were €2.1 million ($2.3 million), down -79.0% from €10.0 million ($11.1 million) during Q2 2014. The merger with Cyberonics into a new entity called LivaNova cost €16.6 million ($18.4 […]
Teleflex updates on Q2 earnings, FDA clearances, acquisitions, deals & study data.
Teleflex (NYSE:TFX) yesterday released a slew of new information on the company, including its fiscal 2nd quarter results, new FDA clearances, the acquisition of Australian distributor assets, details on a new group purchase agreement and data from a set of new studies. Teleflex shares slide on Q2 report Teleflex’s shares dropped nearly 5% today after […]
Glaukos wins iStent nod Down Under
Glaukos (NYSE:GKOS) said today it won approval from the Australian Therapeutic Goods Administration for its iStent Inject trabecular micro-bypass stent designed for use in cataract surgeries to treat glaucoma. The device is indicated for the reduction of intraocular pressure in adult patients with mild-to-moderate glaucoma who are currently being treated with ocular hypotensive medication, the Laguna […]
Abbott drops $250m on Tendyne, backs Cephea in mitral valve play
CEO Miles White proved today that he wasn’t just blowing smoke last week when he said that Abbott (NYSE:ABT) has powder to burn and is ready to use it. Abbott today revealed a pair of investments aimed at building out its presence in the mitral valve replacement market, saying it put another $225 million on top of the […]
Biotronik wins CE Mark for new MRI-safe pacemakers
Biotronik said yesterday it won CE Mark approval in the European Union for 2 next-generation MRI-safe pacemakers. The new devices are compatible with up to 3 tesla MRI scanning machines, the company said. Around 20-30% of MRI machines worldwide are 3T machines, Biotronik said, and the number of these devices is growing. “The benefits of 3 […]
Edwards Lifesciences raises outlook on strong Q2 numbers
(Reuters) — Edwards Lifesciences (NYSE:EW) yesterday raised its full-year profit forecast, citing strong demand for its transcatheter aortic valve implants. Irvine, Calif.-based Edwards reported 2nd-quarter earnings that exceeded Wall Street’s expectations, saying it benefited from significant growth in procedures using its TAVI devices, which are threaded through the arteries to the heart from a small incision. […]
Essential Medical launches Manta device trial
Essential Medical said today it launched a clinical study of its Manta large bore vascular closure device. The Manta system is designed to close large bore punctures following procedures like transcatheter aortic valve replacements, abdominal aortic aneurysm repairs and balloon aortic valvuplasty, the Malvern, Penn.-based company said. Essential Medical said the device is designed to […]
Bellerophon plunges on failed cardiac implant trial
Bellerophon Therapeutics (NSDQ:BLPH) said today that its bioabsorbable cardiac matrix failed to meet both the primary and secondary endpoints in a 303-patient clinical trial, sending its share price down nearly -63% today. BCM is a liquid medical device injected into the coronary artery leading to the damaged area of a heart, and is designed for use after […]
Italian state attorney moves to block Sorin merger with Cyberonics
An Italian state attorney in Milan moved to block the pending, $2.7 billion merger between Sorin Group (BIT:SRN) and Cyberonics (NSDQ:CYBX), seeking to prevent Sorin from dodging a $3.76 billion environmental lawsuit filed against its former corporate parent. Sorin and Cyberonics, which announced the merger in February, plan to re-brand the combined company as LivaNova and […]